| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184743 Use of cholinesterase inhibitors for treating vascular depression |
| 07/22/2010 | US20100184740 Substituted oxazolidinones and their use |
| 07/22/2010 | US20100184731 Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100184729 New Pharmaceutical Compositions for Treatment of Thrombosis |
| 07/22/2010 | US20100184722 Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
| 07/22/2010 | US20100184719 Cetp inhibitors derived from benzoxazole arylamides |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184710 Therapeutic Bifunctional Compounds |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184703 Use of peptide derivatives for treating pathologies resulting from ischemia |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184668 method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 07/22/2010 | US20100184660 Single exon genes encoding for novel bio-active peptides |
| 07/22/2010 | US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 07/22/2010 | US20100184641 Novel Plasma Protein Affinity Tags |
| 07/22/2010 | US20100183718 Compositions and treatment of heart deficiency in non-human animals |
| 07/22/2010 | US20100183717 Controlled-release formulations |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183706 Peptide epitopes of apolipoprotein b |
| 07/22/2010 | US20100183629 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183598 Methods of treating cardiovascular disorders |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183566 METHOD FOR EFFICIENT TRANSFER OF HUMAN BLASTOCYST-DERIVED STEM CELLS (hBS CELLS) FROM A FEEDER-SUPPORTED TO A FEEDER-FREE CULTURE SYSTEM |
| 07/22/2010 | US20100183565 Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183537 Stable and bioavailable compositions of isomers of carotenoids for skin and hair |
| 07/22/2010 | CA2749840A1 Novel eicosanoid derivatives |
| 07/22/2010 | CA2749195A1 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | CA2748718A1 Ointment for the topical treatment of haemorrhoids |
| 07/21/2010 | EP2208728A1 Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase |
| 07/21/2010 | EP2208720A1 Novel eicosanoid derivatives |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2207767A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 07/21/2010 | EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent |
| 07/21/2010 | EP1567197B1 Compositions for treating or preventing angiogenesis-dependent symptoms |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment |
| 07/21/2010 | EP1372529B1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation |
| 07/21/2010 | EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1981750B Soluble A-SH CoA-SH Q10 composition and its production method |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN101784543A Indole and indazole compounds as an inhibitor of cellular necrosis |
| 07/21/2010 | CN101784528A Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 07/21/2010 | CN101784269A methods of treating serotonin-mediated diseases and disorders |
| 07/21/2010 | CN101781351A Method for extracting ginsenoside Rb1 from American ginseng and powder-injection thereof |
| 07/21/2010 | CN101781348A Stable protein kinase activator, preparation method thereof and use |
| 07/21/2010 | CN101781347A Polymorphic substances of decitabine and medical compositions |
| 07/21/2010 | CN101781310A Thiofuran-pyridine [3, 2-c] contained acethydrazide derivative and preparation method and application thereof |
| 07/21/2010 | CN101781287A Irbesartan hydrobromide and preparation method thereof |
| 07/21/2010 | CN101781268A Isothiazole ketone substituted benzene dicarboxylic acid derivative and usage thereof in preparation of beta-secretase inhibitor |
| 07/21/2010 | CN101780268A Method and reagent for diagnosing, preventing and treating insulin resistance |
| 07/21/2010 | CN101780249A Traditional Chinese medicine composition for treating stroke hemiplegia and preparation method thereof |
| 07/21/2010 | CN101780232A Coix seed oil proliposome and preparation method thereof |
| 07/21/2010 | CN101780225A Method for extracting angiotensin I converting enzyme inhibitor from reed leaves |
| 07/21/2010 | CN101780223A Traditional Chinese medicine with integral coordination function for treating ischemic cerebrovascular disease |
| 07/21/2010 | CN101780218A Medicinal lotion for treating haemorrhoids |
| 07/21/2010 | CN101780217A TCM implant for treating haemorrhoids and preparation method thereof |
| 07/21/2010 | CN101780213A Method for preparing ophiopogan total saponies |
| 07/21/2010 | CN101780212A Preparation method of sugar-free traditional Chinese medicine oral liquid for treating angina pectoris |
| 07/21/2010 | CN101780208A TCM preparation for treating subarachnoid hemorrhage |
| 07/21/2010 | CN101780181A Nitric oxide free radical health care product |
| 07/21/2010 | CN101780170A Compound capsule containing root of red-rooted salvia and preparation method and quality determination method thereof |
| 07/21/2010 | CN101780158A Traditional Chinese medicine composition with function of lowering blood pressure and preparation method thereof |
| 07/21/2010 | CN101780151A TCM preparation for treating pulmonary heart disease |
| 07/21/2010 | CN101780141A Method for measuring content of tannin in red sage root extracting solution by near infrared spectrum |
| 07/21/2010 | CN101780140A Drug for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 07/21/2010 | CN101780123A Peganum harmala L extract chewable tablets and preparation method thereof |
| 07/21/2010 | CN101780122A Preparation method of a water-soluble gingko extract |
| 07/21/2010 | CN101780099A Meglumine adenosine cyclophosphate composite medicament |
| 07/21/2010 | CN101780097A Application of DGPP (diacylglycerol pyrophosphate) in preparation of medicines for treating ischemic heart disease |
| 07/21/2010 | CN101780093A Application of progesterone for preparing medicament for treating cerebral apoplexy and cerebral acute reactive inflammation |
| 07/21/2010 | CN101780092A Compounds and methods for delivery of prostacyclin analogs |
| 07/21/2010 | CN101780091A Medical composition containing ivabradine and ranolazine |
| 07/21/2010 | CN101780090A tablet containing valsartan and hydrochlorothiazide |
| 07/21/2010 | CN101780089A Irbesartan hydrochlorothiazide capsule and preparation method thereof |
| 07/21/2010 | CN101780079A Levamlodipine compound drug composition |
| 07/21/2010 | CN101780078A Compound preparation of telmisartan and amlodipine and preparation method thereof |
| 07/21/2010 | CN101780072A Composition of sodium ozagrel and polyethylene glycol and preparation method thereof |